Health Grants for Schools & universities

National Institutes of Health · Amount varies

This NIH (NCATS, UM1) program funds Clinical and Translational Science Award (CTSA) hubs that join a national consortium to accelerate translational research, training, and rapid public health response. Eligible applicants are U.S. research organizations including universities, government and tribal entities, and faith- or community-based organizations; foreign organizations and non-U.S. components are not eligible, though some foreign components are allowed. It is aimed at major academic medical and research institutions capable of operating a CTSA hub, not individuals or general nonprofits. Award amounts are not specified but such hubs are typically large, multi-year awards.

National Institutes of Health · Amount varies

This NIH (NCATS, T32) program funds eligible institutions to provide postdoctoral research training in clinical and translational science for individuals holding doctoral degrees across many health disciplines. This is a limited competition; foreign institutions and non-U.S. components of U.S. organizations are not eligible to apply. It is intended for U.S. research institutions, not individuals or general nonprofits. Award amounts are not specified, and the limited-competition framing suggests eligibility may be restricted to specific existing programs.

National Institutes of Health · Up to $250K

This NIH R25 funds research experiences and mentoring networks that help clinician-scientists engage in NIDCD-relevant hearing, voice, speech, and communication research. Eligible applicants are research and educational institutions, including minority- and tribal-serving colleges, though foreign organizations are excluded. Awards go up to $250,000.

National Institutes of Health · Amount varies

This NIH BRAIN Initiative U01 funds development of scalable technologies to map brain connectivity across scales in humans, non-human primates, and mice, feeding into the BRAIN CONNECTS network; no clinical trial is allowed. Eligibility is described in the funding notice, and foreign organizations and their U.S. components may apply. No award amount is specified. Funded projects must integrate into a coordinated network, so review the notice's eligibility details carefully.

National Institutes of Health · Amount varies

This NIH/NCI U01 funds cancer etiology and early-detection biomarker research that must use the NCI-sponsored PLCO Screening Trial biospecimen resource. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, tribal governments, foreign organizations, and U.S. territories; it targets research organizations, not individuals. No award amount is specified. Projects that do not use PLCO biospecimens will not be funded, which narrows eligibility significantly.

National Institutes of Health · Amount varies

This NIH/NINDS U01 funds IND-enabling studies and planning for first-in-human testing of gene-based therapies for ultra-rare neurological and neuromuscular disorders. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; foreign organizations are not eligible, and it targets research organizations rather than individuals. No award amount is specified. The ultra-rare gene-therapy focus makes eligibility narrow.

National Institutes of Health · Up to $500K

This NIH/NIDCD R01 funds translational research that turns basic findings into clinical tools for communication disorders such as hearing, balance, voice, speech, and language. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; it targets research organizations, not individuals. Awards reach up to about $500,000. Projects must show a clear clinical connection and practical impact, so the scope is specific.

National Institutes of Health · Amount varies

This NIH/NCI K99/R00 career award supports postdoctoral cancer researchers transitioning to independent faculty positions, with a clinical trial required. It is applied for through a host research or education institution but effectively targets individual early-career investigators; foreign organizations are not eligible. No award amount is specified. Applicants should confirm they meet the career-stage and eligibility criteria, which are specific.

National Institutes of Health · Amount varies

This NIH/NCI K99/R00 career award supports postdoctoral cancer researchers transitioning to independent faculty positions, providing mentored and then independent research funding. It is applied for through a host research or education institution, but it effectively targets individual early-career investigators who meet eligibility requirements; foreign organizations are not eligible. No award amount is specified. Applicants should confirm they meet the career-stage and eligibility criteria, which are specific.

National Institutes of Health · Amount varies

This NIH/NIMH award (R61/R33) funds feasibility work followed by clinical trials testing mental-health system interventions to improve the organization, delivery, and outcomes of mental health services. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; it targets research organizations rather than individuals. No award amount is specified. The focus on system-level interventions and required clinical trial make the scope narrow.

National Institutes of Health · Amount varies

This NIH/NIMH R01 funds pilot effectiveness trials of mental health treatment, prevention, and services interventions, with a clinical trial required. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; it targets research organizations rather than individuals. No award amount is specified. Studies must follow NIMH's experimental-therapeutics approach, so the scope is specific.

National Institutes of Health · Amount varies

This NIH/NIDCD R21 early-career award supports basic and clinical research by scientists beginning an independent research career in NIDCD mission areas such as hearing, balance, smell, taste, voice, speech, or language. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; foreign organizations are not eligible. It cannot fund thesis or dissertation research, and is intended to generate preliminary data for a later R01. No award amount is specified.

National Institutes of Health · Amount varies

This NIH/NIMH award (R61/R33) funds early-stage testing of pharmacologic or device-based interventions for mental disorders, with a clinical trial required. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; it targets research organizations rather than individuals. No award amount is specified. Studies must follow NIMH's experimental-therapeutics design, so the scope is specific.

National Institutes of Health · Amount varies

This NIH/NIMH R33 grant funds early-stage testing of pharmacologic or device-based interventions for mental disorders, with a clinical trial required. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; it is aimed at research organizations rather than individuals. No award amount is specified. The study must follow NIMH's experimental-therapeutics design requirements, so the scope is narrow.

National Institutes of Health · Amount varies

This NIH/NIMH R33 grant funds pilot research developing and testing novel psychosocial therapeutic and preventive interventions for mental disorders, with a clinical trial required. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; it is geared toward research organizations rather than individuals. The award amount is not specified in the listing. Applicants must use the experimental-therapeutics approach described, so the research focus is narrow.

National Institutes of Health · Amount varies

This NIH/NIMH award (R61/R33) funds development and testing of novel psychosocial therapeutic and preventive interventions for mental disorders, with a clinical trial required. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; it targets research organizations rather than individuals. No award amount is specified. Work must follow NIMH's experimental-therapeutics approach, so the scope is specific.

National Institutes of Health · Amount varies

This NIH/NIMH R01 funds full-scale hybrid effectiveness-implementation clinical trials of mental health treatment, prevention, or services interventions in community and practice settings, with a clinical trial required. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; it targets research organizations rather than individuals. No award amount is specified. Trials must be well-powered and follow NIMH's experimental-therapeutics approach, so the scope is specific.

National Institutes of Health · Amount varies

This NIH/NIMH R01 funds confirmatory efficacy clinical trials of non-pharmacological and pharmacological interventions for mental disorders in adults and children, with a clinical trial required. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; it targets research organizations rather than individuals. No award amount is specified. Trials must follow NIMH's experimental-therapeutics design, so the scope is narrow.

National Institutes of Health · Amount varies

This NIH/NIMH U01 cooperative agreement funds first-in-human and early-stage clinical trials of novel investigational drugs or neuromodulatory devices for psychiatric disorders, with a clinical trial required. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; foreign organizations are not eligible, and it targets research organizations rather than individuals. No award amount is specified. It emphasizes academia-industry partnerships, so the scope is narrow.

National Institutes of Health · Amount varies

This NIH/NEI R21 funds vision-related research projects based on secondary analysis of existing datasets, including related statistical methodology development; no clinical trial is allowed. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; it targets research organizations rather than individuals. No award amount is specified. The focus is limited to vision-related secondary data analysis.